Navigation Links
Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call
Date:2/18/2011

osition of the Company's currently marketed products, newly acquired products and product candidates that are currently in development; to grow product revenue through the Company's specialty sales forces; and to maintain and strengthen the intellectual property position of the Company's currently marketed products, newly acquired products and product candidates.

Safe Harbor StatementThis press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein, other than statements of historical fact, including statements regarding the progress and timing of our product development programs and related trials, our strategy and our future operations and opportunities, constitute forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the results of preclinical studies and clinical trials with respect to our products under development, our ability to satisfy FDA and other regulatory requirements, our ability to enter into strategic licensing, product acquisition, collaboration or co-promotion transactions on favorable terms, if at all, and the other factors described in Item 1A (Risk Factors) of our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the SEC) on March 4, 2010 and in our subsequent filings with the SEC. In addition, the statements in this press release reflect our expectations and beliefs as of the date of this release, should not be relied upon as representing our views as of any other date and do not reflect the potential impact of any acquisitions, mergers, dispositions, business development transactions, joint ventures or investments that we may make or enter into. We anticipate that subsequent events and developments will cause our expectations and beliefs to change. However, while we may elect
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call
2. Cornerstone Therapeutics Announces Development of Generic for Tussionex®
3. Cornerstone Therapeutics Licenses Alpha-7 Technology to Targacept
4. Cornerstone Therapeutics Announces Collaboration with The Cough Company
5. Cornerstone Therapeutics to Host Second Quarter 2010 Conference Call
6. Cornerstone Therapeutics Announces Management Change
7. Cornerstone Therapeutics To Present at Deutsche Banks 35th Annual Healthcare Conference
8. Cornerstone Therapeutics to Host First Quarter 2010 Conference Call
9. Cornerstone Therapeutics to Present at the 30th Annual Cowen & Company Health Care Conference
10. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
11. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 Research ... the addition of the "North American ... Digit Replacement, Elbow Replacement, Hip Replacement, Knee ... report to their offering. ,     (Logo: ... was valued at $4,470.9 million in 2014 ...
(Date:5/21/2015)... 21, 2015  CryoLife, Inc. (NYSE: CRY ), ... on cardiac and vascular surgery, announced today that its ... for the second quarter 2015 of $0.03 per share ... $0.03 per share will be paid on June 19, ... June 12, 2015.  The ex-dividend date for the quarterly ...
(Date:5/21/2015)... CAMBRIDGE, England , May 21, ... zur Bekämpfung von Arzneimittelfälschungen - Zwecks ... eines Arzneimittelprüfdienstes wird auf EG-Mitgliedstaaten verwiesen, ... Pilotsysteme betrieben werden.  Wählen Sie ein ... Bei der Richtlinie zur Bekämpfung von ...
Breaking Medicine Technology:North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3
... As recently reported in the North County Times , the Partnership ... million uninsured and financially struggling Americans obtain access to the medicines they need ... , , , ... new online tools that expand community partnerships and enhance PPA,s mobile ...
... May 12 The New England Journal of Medicine ... Some of the whistleblower cases discussed in the report were brought by Phillips ... and San Francisco . Phillips & Cohen has specialized in representing whistleblowers ... , , ...
Cached Medicine Technology:PPA 2.0 Makes Getting Prescription Assistance Easier 2PPA 2.0 Makes Getting Prescription Assistance Easier 3Whistleblower Lawyers Comment on New England Journal of Medicine Study 2Whistleblower Lawyers Comment on New England Journal of Medicine Study 3
(Date:5/24/2015)... May 24, 2015 For people who ... Chinese Enterokinase Industry, 2009-2019 Market Research Report would be ... an exhaustive study on the present market scenario of ... into the growing Chinese market of this industry. The ... overall status of the manufacturers in this industry. The ...
(Date:5/24/2015)... 2015 The federal court overseeing ... has scheduled its next monthly Case Management Conference ... According to court documents filed in the U.S. ... will be convened on June 2, 2015, at ... Liability Litigation - MDL No. 2545) , “Our ...
(Date:5/24/2015)... Lake Geneva, WI (PRWEB) May 24, ... Bea Mercy Health System CEO ... their principal and honored at the ... event held April 15 at Geneva ... include (by school): ,     -Badger High ...
(Date:5/23/2015)... 2015 Dr. David Benvenuti, an experienced plastic ... a new article to his website that takes ... Benvenuti explained in the fascinating blog, he has recently ... earlobes. , Known as “gauging,” the technique involves placing larger ... Benvenuti said will eventually stretch the holes out to incredible ...
(Date:5/23/2015)... Manufacturers are now required to produce water heaters with a ... the field agree that the regulation is aimed at manufacturers, ... what miles per gallon is to your car. The higher ... HSPF score has been raised to 8.2, technology has since ... 12. Indeed, the regulation was welcomed by environmentalist, and members ...
Breaking Medicine News(10 mins):Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2
... Conduct, Webcast For Veterinarians, Covering All Aspects Related ... Morris Animal Foundation (MAF) will,sponsor a live webcast for ... 7:00 p.m. to 8:00 p.m. (Eastern Daylight Time). The ... concern for the,veterinarian, including common pain issues, overlooked causes ...
... MELVILLE, N.Y., March 3 Gentiva Health,Services, Inc. ... of,comprehensive home health services, announced today that it ... interest in Home Health Care,Affiliates, Inc. and certain ... in cash, subject to post-closing adjustments., The ...
... Helps Life Sciences Organizations ... Efficiently and Effectively, BARCELONA, Spain, March 3 ... Oracle(R) Remote,Data Capture Onsite 4.5.3, the newest version of ... life sciences organizations,and contract research organizations (CROs) conduct clinical ...
... March 2 Eisai Corporation of,North America, its ... today announced that the U.S. Food and Drug ... the,prevention of postoperative nausea and vomiting (PONV) for ... hours has not been demonstrated., Aloxi, available ...
... cope with loss of hour,s sleep on March 9 , , ... few simple steps can help you minimize the impact of lost ... says the American Academy of Sleep Medicine. , The academy offers ... Time (DST): , Begin to readjust your sleep schedule a ...
... a lesser-used medication could boost odds for lymphoma, study ... Methotrexate, one of the most common drugs used to ... risk for blood cancer, a new study finds. , ... doubling in patients, odds for lymphoma, the Canadian researchers ...
Cached Medicine News:Health News:Pain Management For Pets, Key Strategies For Veterinarians - Live Webcast to Veterinarians, March 13, 7:00 p.m. to 8:00 p.m. (EDT) Via Morris Animal Foundation 2Health News:Gentiva(R) Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi 2Health News:Gentiva(R) Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi 3Health News:Oracle Introduces Remote Data Capture Onsite 4.5.3 With Extensive New Functionality for Investigative Site Personnel 2Health News:Oracle Introduces Remote Data Capture Onsite 4.5.3 With Extensive New Functionality for Investigative Site Personnel 3Health News:Oracle Introduces Remote Data Capture Onsite 4.5.3 With Extensive New Functionality for Investigative Site Personnel 4Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 2Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 3Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 4Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 5Health News:Common Rheumatoid Arthritis Drug Won't Raise Blood Cancer Risk 2Health News:Common Rheumatoid Arthritis Drug Won't Raise Blood Cancer Risk 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: